These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A cross-sectional study in the USA of the epidemiology and quality of life of underactive bladder symptoms. Faraj K; Doo F; Boura J; Vereecke A; Chancellor MB Int Urol Nephrol; 2016 Nov; 48(11):1797-1802. PubMed ID: 27473156 [TBL] [Abstract][Full Text] [Related]
5. Defining and advancing education and conservative therapies of underactive bladder. Griebling TL; DuBeau CE; Kuchel G; Wilde MH; Lajiness M; Tomoe H; Diokno A; Vereecke A; Chancellor MB Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S29-34. PubMed ID: 25238892 [TBL] [Abstract][Full Text] [Related]
6. Advanced therapeutic directions to treat the underactive bladder. Smith PP; Tyagi P; Kuchel GA; Pore S; Chermansky C; Chancellor M; Yoshimura N; Levanovich P Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S35-44. PubMed ID: 25238893 [TBL] [Abstract][Full Text] [Related]
7. Transcutaneous interferential electrical stimulation for the management of non-neuropathic underactive bladder in children: a randomised clinical trial. Kajbafzadeh AM; Sharifi-Rad L; Ladi-Seyedian SS; Mozafarpour S BJU Int; 2016 May; 117(5):793-800. PubMed ID: 26086897 [TBL] [Abstract][Full Text] [Related]
8. [How Does one Avoid Micturition? A Question That not Only Children ask]. Jäckel K; Schwab C; Knechtle B Praxis (Bern 1994); 2016 May; 105(11):657-61. PubMed ID: 27223419 [TBL] [Abstract][Full Text] [Related]
9. Decreasing frequency pattern in patients with clean intermittent catheterization for bladder voiding dysfunction. Batista-Miranda JE; Martínez P; Bassas-Parga A Arch Esp Urol; 2014 Dec; 67(10):831-8. PubMed ID: 25582902 [TBL] [Abstract][Full Text] [Related]
10. Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome). Panicker JN; Seth JH; Khan S; Gonzales G; Haslam C; Kessler TM; Fowler CJ BJU Int; 2016 May; 117(5):809-13. PubMed ID: 26435296 [TBL] [Abstract][Full Text] [Related]
11. The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study. Mehnert U; Birzele J; Reuter K; Schurch B J Urol; 2010 Sep; 184(3):1011-6. PubMed ID: 20643431 [TBL] [Abstract][Full Text] [Related]
12. Patient-reported side effects of intradetrusor botulinum toxin type a for idiopathic overactive bladder syndrome. Bauer RM; Gratzke C; Roosen A; Hocaoglu Y; Mayer ME; Buchner A; Stief CG; May F Urol Int; 2011; 86(1):68-72. PubMed ID: 20639617 [TBL] [Abstract][Full Text] [Related]
13. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396 [TBL] [Abstract][Full Text] [Related]
14. Updates of underactive bladder: a review of the recent literature. Li X; Liao L Int Urol Nephrol; 2016 Jun; 48(6):919-30. PubMed ID: 26931421 [TBL] [Abstract][Full Text] [Related]
15. Pilot study evaluating the safety of intradetrusor injections of botulinum toxin type A: investigation of generalized spread using single-fiber EMG. Schnitzler A; Genet F; Durand MC; Roche N; Bensmail D; Chartier-Kastler E; Denys P Neurourol Urodyn; 2011 Nov; 30(8):1533-7. PubMed ID: 21661038 [TBL] [Abstract][Full Text] [Related]
16. Intradetrusor botulinum neurotoxin A (BoNT-A) injections decrease bladder fibrosis secondary to partial urethral obstruction in the male rat model. Tinay I; Tanidir Y; Cikler E; Cetinel S; Tarcan T Neurourol Urodyn; 2012 Apr; 31(4):564-70. PubMed ID: 22275224 [TBL] [Abstract][Full Text] [Related]
17. Crystallizing the Definition of Underactive Bladder Syndrome, a Common but Under-recognized Clinical Entity. Chapple CR; Osman NI Low Urin Tract Symptoms; 2015 May; 7(2):71-6. PubMed ID: 26663685 [TBL] [Abstract][Full Text] [Related]
18. New technology assessment and current and upcoming therapies for underactive bladder. Chancellor MB; Bartolone SN; DeVries EM; Diokno AC; Gibbons M; Jankowski R; Lamb LE; Pruchnic R; Thor K; Dmochowski R Neurourol Urodyn; 2018 Nov; 37(8):2932-2937. PubMed ID: 29953660 [TBL] [Abstract][Full Text] [Related]